Malaysian Genomics Resource Centre Bhd (XKLS:0155) Growth Rank: 3 (As of Sep. 01, 2026) — 40% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0155 Malaysian Genomics Resource Centre Bhd XKLS:0155
46 GF Score
Price RM0.37
GF Value RM0.31
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Malaysian Genomics Resource Centre Bhd Growth Rank?

Malaysian Genomics Resource Centre Bhd XKLS:0155 46 Growth Rank is 3 as of Sep. 01, 2026, which is 40% below its 10-year median of 5.00. GuruFocus rates XKLS:0155 with a GF Score™ of 46/100 and a GF Value™ of RM0.31 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Malaysian Genomics Resource Centre Bhd has the Growth Rank of 3.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Malaysian Genomics Resource Centre Bhd Growth Rank Related Terms

XKLS:0155 vs TMO, DHR, NTRA: Growth Rank Comparison

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Malaysian Genomics Resource Centre Bhd Growth Rank vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Growth Rank distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Growth Rank falls into.


XKLS:0155
46GF Score
Malaysian Genomics Resource Centre Bhd XKLS:0155
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 3 mean?
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a Growth Rank of 3 as of Sep. 01, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. This is 40% below median its historical median of 5.00. Over the past decade, Malaysian Genomics Resource Centre Bhd's Growth Rank has ranged from 2.00 to 9.00.
Is Malaysian Genomics Resource Centre Bhd's Growth Rank too high?
Malaysian Genomics Resource Centre Bhd's current Growth Rank of 3 is 40% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's Growth Rank compare to TMO and DHR?
Malaysian Genomics Resource Centre Bhd's Growth Rank of 3 can be compared against companies in the Medical Diagnostics & Research industry. Historically, Malaysian Genomics Resource Centre Bhd's own Growth Rank has ranged from 2.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Diagnostics & Research company?
A good Growth Rank depends on the Medical Diagnostics & Research industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. Malaysian Genomics Resource Centre Bhd's current Growth Rank is 3, which is 40% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.37 — trading 19.4% above its estimated fair value. The current Growth Rank is 3, which is 40% below median its 10-year median of 5.00. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current Growth Rank is 3 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?

Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be overvalued. The current stock price of RM0.37 is trading 19.4% above its estimated GF Value™ of RM0.31. GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Modestly Overvalued.

Key valuation signals for XKLS:0155:

  • Growth Rank: 3 (40% below median its 10-year median of 5.00)
  • GF Value™: RM0.31 vs. price of RM0.37 (19.4% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Malaysian Genomics Resource Centre Bhd Business Description

Address Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
46GF Score

Get the complete analysis for XKLS:0155

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.37
Price
RM0.31
GF Value